APVO - Company ID 0001671584
The table below shows Aptevo Therapeutics Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $9.80M | $14.53M | $21.06M | $9.41M | $2.14M | $7.75M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $10.80M |
| $15.98M |
| $22.65M |
| $11.08M |
| $3.61M |
| $10.01M |
| Property, plant & equipment | $236.00K | $268.00K | $384.00K | $432.00K | $482.00K | $614.00K |
| Goodwill | - | - | - | - | - | - |
| Total assets | $14.52M | $19.90M | $27.00M | $15.62M | $8.34M | $15.15M |
| Accounts payable | $1.16M | $890.00K | - | - | - | - |
| Total current liabilities | $5.19M | $4.76M | $5.61M | $4.89M | $5.39M | $5.88M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $8.48M | $8.29M | $9.60M | $9.10M | $9.81M | $10.73M |
| Retained earnings | -$288.26M | -$281.91M | -$269.22M | -$260.19M | -$253.99M | -$241.26M |
| Total equity | $6.04M | $11.61M | $17.39M | $6.52M | -$1.47M | $4.42M |